Use of alpha 2 adrenergic receptor antagonists for the production of pharmaceutical compositions for treating colonic spasm, irritable bowel syndrome and constipation and process for preparing such pharmaceutical compositions
申请人:Merck & Co., Inc.
公开号:EP0216247A2
公开(公告)日:1987-04-01
Selective α₂-adrenergic receptor antagonists are effective in modifying gastro-intestinal motility in a manner useful in the treatment of colonic spasm, irritable bowel syndrome and constipation.